Healthcare ❯ Pharmaceuticals ❯ Drug Approval

FDA Regulations

Clinical Trials Off-Label Use Leqembi Semaglutide Clinical Research Wegovy Medication Access Chronic Kidney Disease Hypertension Treatments Addyi Eli Lilly Abbreviated New Drug Application Compounding Drugs Mifepristone Safety Review

3 ARTICLES

last mo.

FDA Scrutinizes Testosterone Use for Menopausal Women

Experts said long-term safety and dosing remain unresolved, prompting calls for targeted trials, standardized products, clinician training, clearer coverage and better data

3 ARTICLES

last mo.

FDA Expands Addyi Use to Postmenopausal Women, Including Those Over 65

FDA Regulations

FDA Scrutinizes Testosterone Use for Menopausal Women

Judge Pauses Texas-Florida Mifepristone Lawsuit Pending FDA Review

Supreme Court Clears Path for Generic 'Skinny Labels' in Unanimous Hikma Ruling

Eli Lilly Builds $1.5 Billion Stockpile of Orforglipron as FDA Decision Nears

Shareholder Law Firms Expand Probes of Corcept After FDA CRL for Relacorilant

FDA Expands Addyi Use to Postmenopausal Women, Including Those Over 65